Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

UNBELIEVABLE: 4 | History Defined

Revealed: the crypto entrepreneur linked to illegal weight-loss drug operation

Haul of illicit products led by medicines regulator was described as world’s largest of its kind, but no arrests have yet been made

The Guardian - UK

Novo Nordisk launches Wegovy weight-loss pill in US, triggering price war

First and only GLP-1 pill on the market costs significantly less than injectable versions

The Guardian - UK

NHS Refuses to Fund Life-Saving Motor Neurone Disease Medication Despite Free Supply From Drugmaker

MND patients in the UK denied access to lifesaving drug tofersen, despite Biogen supplying it free, due to NHS covering administration costs.

International Business Times UK

From analysis to the latest developments in health,
read the most diverse news in one place.

US Drug Pricing Deal May Lead to Swiss Medicine Price Hikes

US drug price cuts may push up the cost of new medicines in Switzerland, Roche's CEO warns.

International Business Times

PPE company linked to ex-Tory peer Michelle Mone goes into liquidation

PPE Medpro owes government £148m for supplying unusable personal protective equipment during Covid-19 pandemic

The Guardian - UK

PPE Medpro wound up after being ordered to pay £148m to Government

The decision could mean that the Government is unlikely to see most of the £148 million owed to it by the company.

Evening Standard

The UK’s pharma deal was vital – but the GSK boss is right about US dominance

It would be absurd to claim the UK has suddenly become a life-sciences leader thanks to the new pricing and tariffs pact

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

US is the best place for drug companies to invest, says boss of London-based GSK

Emma Walmsley’s praise for US pharmaceutical market piles pressure on UK government

The Guardian - UK

Texas and Florida sue FDA in latest effort to restrict abortion pill access

States’ attorneys general argue agency has failed to properly evaluate mifepristone’s safety since initial 2000 approval

The Guardian - US

What's Going On With The Surge In Diginex Stock?

Diginex Ltd (NASDAQ:DGNX) shares are trading higher on Tuesday. The Sustainability RegTech Solutions provider posted financial results, highlighted by sharp revenue growth and a stronger balance sheet.

Benzinga

Healthcare Relevancies Clashes With Premium Valuations For Direxion's LLY-Focused ELIL, ELIS ETFs

In terms of sheer relevance, it's difficult to think of a more relevant sector than healthcare — and within this vast ecosystem, only an elite few occupy the same neighborhood as pharmaceutical giant Eli Lilly and Company (NYSE:LLY). In November 2025, Eli Lilly became the first trillion-dollar pharmaceutical company, mostly…

Benzinga

Eli Lilly, Pfizer Among 19 Drugs Approved for China's Commercial Health Insurance

China approves 19 innovative drugs for commercial health insurance, opening new market opportunities for global and local drugmakers.

International Business Times

Company linked to raid on illicit weight-loss drug facility still selling unlicensed drugs

Alluvi continues sales on Telegram after MHRA seized counterfeit, unlicensed retatrutide and tirzepatide pens

The Guardian - UK

Praxis' Epilepsy Drug Too Good To Continue, FDA Meeting Up Next

Praxis Precision Medicines Inc. (NASDAQ:PRAX) stock rose Friday after the company shared results from the registrational cohort of the EMBOLD study evaluating relutrigine for the treatment of patients with SCN2A and SCN8A developmental and epileptic encephalopathies (DEEs).

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Denali Flags Minimal Delay After FDA Halts Rare Disease Trial Start

The U.S. Food and Drug Administration (FDA) placed a clinical hold on Denali Therapeutics Inc.’s (NASDAQ:DNLI) investigational new drug (IND) application for the Phase 1 study of DNL952 under development for Pompe disease.

Axios

FDA reaches "tipping point" after high-level departures

Biotech and pharmaceutical companies rely on the FDA for guidance as they spend huge sums developing treatments.

Benzinga

Why UiPath Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket

Shares of UiPath Inc. (NYSE:PATH) rose sharply in pre-market trading after the company reported upbeat third-quarter financial results and issued fourth-quarter sales guidance with its midpoint above estimates.

Benzinga

Why Are Torrid Holdings (CURV) Shares Falling After Hours?

Torrid Holdings Inc. (NYSE:CURV) shares fell 14.5% to $1.12 in after-hours trading on Wednesday after the retailer reported its third-quarter fiscal results.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

These Healthcare Stocks Just Exploded In Momentum — Investors Are Taking Notice

In the pulsating world of healthcare stocks, Elekta Inc. (OTC:EKTAY) has distinguished itself this week with a staggering 129% surge in its momentum score, leaping from 19.90 to 45.67. Elekta, a renowned manufacturer of medical equipment, found its stock trading at $5.86 on Wednesday, unmoved from the previous day’s close but comfortably…

Benzinga

Analyst Says Viridian's New Thyroid Eye Drug Could Outperform Amgen's Tepezza

William Blair initiated coverage on Viridian Therapeutics Inc. (NASDAQ:VRDN) on Wednesday.

Benzinga

Capricor Stock Soars, Shkreli Is Short: Here's What Pharma Bro Had To Say

Capricor Therapeutics, Inc. (NASDAQ:CAPR) stock soared on Wednesday after the company announced positive topline data from the Phase 3 HOPE-3 trial for its lead cell therapy candidate, deramiocel.

The Independent UK

A biotech company is beginning trials for a fentanyl vaccine. The CEO says it ‘could completely change’ how overdoses are treated

Human trials are scheduled to begin in the Netherlands early next year

International Business Times UK

The Fastest Tariff U-Turn in History: How Britain Made Trump Blink on Pharmaceuticals

Fastest tariff reversal ever: Britain wins zero-tariff pharma deal as Trump backs down—NHS faces 25% higher drug costs. See effects on patients and jobs.

The Guardian - UK

NHS to pay 25% more for innovative drugs after UK–US zero-tariff deal

Agreement could cost NHS an extra £3bn a year, industry sources estimate

The Guardian - UK

Illegal weight-loss drugs being sold in UK by firms with high Trustpilot scores

Exclusive: Guardian investigation finds unlicensed jabs offered as experts call for more online regulation

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.